Trevi Therapeutics, Inc. (TRVI): $1.98

-0.05 (-2.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Trevi Therapeutics Inc (TRVI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering TRVI.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $12 $10 $11 $1.95 464.1%

The Trend in the Analyst Price Target


Over the past 147 days, TRVI's average price target has gone down $0.

TRVI reports an average of 325.1% for its upside potential over the past 14 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 2 12 10 11.00 1.970 458.38%
2021-07-10 3 12 10 11.33 2.100 439.52%
2021-07-03 3 12 10 11.33 2.150 426.98%
2021-06-26 3 12 10 11.33 2.190 417.35%
2021-06-13 3 12 10 11.33 2.230 408.07%
2021-06-05 3 12 10 11.33 2.107 437.73%
2021-05-22 3 12 10 11.33 1.995 467.92%
2021-05-15 3 12 10 11.33 2.060 450%
2021-05-08 3 13 10 11.67 2.100 455.71%
2021-04-25 3 13 10 11.67 2.340 398.72%
2021-04-17 3 13 10 11.67 2.400 386.25%
2021-04-10 3 13 10 11.67 2.610 347.13%
2021-04-03 3 13 10 11.67 2.750 324.36%
2021-03-20 3 13 10 11.67 2.750 324.36%
2021-03-13 4 13 9 11.00 2.700 307.41%
2021-03-06 4 13 9 11.00 2.380 362.18%
2021-02-27 4 13 9 11.00 2.820 290.07%
2021-02-20 4 13 9 11.00 3.070 258.31%
2021-02-13 4 13 9 11.00 3.240 239.51%
2021-02-06 4 13 9 11.00 3.390 224.48%
2021-01-30 4 13 9 11.00 2.980 269.13%
2021-01-23 4 13 9 11.00 2.970 270.37%
2021-01-16 4 13 9 11.00 3.010 265.45%
2021-01-09 4 13 9 11.00 2.930 275.43%
2021-01-02 4 13 9 11.00 2.420 354.55%
2020-12-26 4 13 9 11.00 2.790 294.27%
2020-12-19 4 13 9 11.00 2.860 284.62%
2020-12-10 4 13 9 11.00 3.165 247.55%
2020-12-07 4 13 9 11.00 3.005 266.06%
2020-11-28 4 13 9 11.00 3.085 256.56%
2020-10-28 4 13 9 11.00 3.130 251.44%
2020-09-23 4 13 9 11.00 3.920 180.61%
2020-08-14 4 13 9 11.00 5.860 87.71%
2020-07-10 4 13 8 10.75 NA NA%
2020-05-12 4 18 8 13.25 NA NA%

TRVI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 1 1 0 0 0 2

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Trevi Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 97.07% of all US stocks.
  • TRVI has a greater number of analysts covering the stock than 13.89% of Healthcare stocks.
  • Trevi Therapeutics Inc's average analyst price target is greater than 21.02% of all US stocks.
  • TRVI has a lower variance in analysts' estimates than 77.95% of Pharmaceutical Products stocks.

Stocks similar to Trevi Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ACRX, SLRX and MBRX.

What is the outlook for TRVI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.661 seconds.